iRhythm Holdings, Inc. (IRTC) stock
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/303% below fair value
$94.87+5.20 (+5.80%)
Close on Nov 18, 2026Market cap $3.13BP/E –Yield –
iRhythm operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
iRhythm's operating income for the twelve months ending Jun 30, 2026 was -$24.87M. For fiscal 2025 it was -$57.41M. The highest annual figure on record is -$14.77M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$57.41M | – |
| FY2024 | Dec 31, 2024 | -$115.51M | – |
| FY2023 | Dec 31, 2023 | -$125.16M | – |
| FY2022 | Dec 31, 2022 | -$113.78M | – |
| FY2021 | Dec 31, 2021 | -$99.94M | – |
| FY2020 | Dec 31, 2020 | -$43.67M | – |
| FY2019 | Dec 31, 2019 | -$54.76M | – |
| FY2018 | Dec 31, 2018 | -$45.69M | – |
| FY2017 | Dec 31, 2017 | -$27.59M | – |
| FY2016 | Dec 31, 2016 | -$15.58M | – |
| FY2015 | Dec 31, 2015 | -$21.63M | – |
| FY2014 | Dec 31, 2014 | -$14.77M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.54M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.19M | – |
| Q4 FY2025 | Dec 31, 2025 | $2.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$32.56M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.08M | – |
| Q3 FY2024 | Sep 30, 2024 | -$50.30M | – |
| Q2 FY2024 | Jun 30, 2024 | -$22.98M | – |
| Q1 FY2024 | Mar 31, 2024 | -$38.14M | – |
| Q4 FY2023 | Dec 31, 2023 | -$39.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$27.60M | – |
| Q2 FY2023 | Jun 30, 2023 | -$18.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$39.50M | – |
| Q4 FY2022 | Dec 31, 2022 | -$20.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.09M | – |
| Q2 FY2022 | Jun 30, 2022 | -$23.45M | – |
| Q1 FY2022 | Mar 31, 2022 | -$48.55M | – |
| Q4 FY2021 | Dec 31, 2021 | -$32.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$23.28M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.99M | – |
| Q1 FY2021 | Mar 31, 2021 | -$27.47M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.58M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.76M | – |
| Q2 FY2020 | Jun 30, 2020 | -$20.16M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.17M | – |
| Q4 FY2019 | Dec 31, 2019 | -$17.73M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.26M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.20M | – |
| Q4 FY2018 | Dec 31, 2018 | -$13.09M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.22M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.78M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.94M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.98M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.92M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.75M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.35M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.67M | – |
See a number that looks wrong?